Evidence map›Paper›PMID 40243782›Full record

ReviewInternational journal of molecular sciences2025

The Therapeutic Use and Potential of MSCs: Advances in Regenerative Medicine.

Alin Constantin Pînzariu, Roxana Moscalu, Radu Petru Soroceanu, Minela Aida Maranduca, Ilie Cristian Drochioi, Vlad Ionut Vlasceanu, Sergiu Timofeiov, Daniel Vasile Timofte, Bogdan Huzum, Mihaela Moscalu and 2 more

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Special Issue: Toxicity of Metals, Metal-Based Drugs, and Microplastics.International journal of molecular sciences · 2026
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Alin Constantin PînzariuDepartment of Morpho-Functional Sciences II, Discipline of Physiology, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.ORCID 0000-0001-5730-1662
Roxana MoscaluDivision of Cell Matrix Biology & Regenerative Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9PL, UK.ORCID 0000-0002-3450-7200
Radu Petru SoroceanuDepartment of Surgery I, Discipline of Surgical Semiology, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
Minela Aida MaranducaDepartment of Morpho-Functional Sciences II, Discipline of Physiology, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.ORCID 0000-0002-2736-9700
Ilie Cristian DrochioiDepartment of Oral and Maxillo Facial Surgery, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
Vlad Ionut VlasceanuDepartment of Surgery I, Discipline of Surgical Semiology, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
Sergiu TimofeiovDepartment of Surgery I, Discipline of Surgical Semiology, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
Daniel Vasile TimofteDepartment of Surgery I, Discipline of Surgical Semiology, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.ORCID 0000-0002-6604-874X
Bogdan HuzumDepartment of Orthopaedic and Traumatology, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
Mihaela MoscaluDepartment of Preventive Medicine and Interdisciplinarity, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.ORCID 0000-0002-8899-8594
Dragomir Nicolae SerbanDepartment of Morpho-Functional Sciences II, Discipline of Physiology, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
Ionela Lacramioara SerbanDepartment of Morpho-Functional Sciences II, Discipline of Physiology, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mesenchymal stem cells (MSCs) have emerged as a relevant strategy in regenerative medicine due to their multipotent differentiation capacity, immunomodulatory properties, and therapeutic applications in various medical fields. This review explores the therapeutic use of MSCs, focusing on their role in treating autoimmune disorders and neoplastic diseases and in tissue regeneration. We discuss the mechanisms underlying MSC-mediated tissue repair, including their paracrine activity, migration to injury sites, and interaction with the immune system. Advances in cellular therapies such as genome engineering and MSC-derived exosome treatments further enhance their applicability. Key methodologies analyzed include genomic studies, next-generation sequencing (NGS), and bioinformatics approaches to optimize MSC-based interventions. Additionally, we reviewed preclinical and clinical evidence demonstrating the therapeutic potential of MSCs in conditions such as graft-versus-host disease, osteoarthritis, liver cirrhosis, and neurodegenerative disorders. While promising, challenges remain regarding standardization, long-term safety, and potential tumorigenic risks associated with MSC therapy. Future research should focus on refining MSC-based treatments to enhance efficacy and minimize risks. This review underscores the need for large-scale clinical trials to validate MSC-based interventions and fully harness their therapeutic potential.

Indexed as

Mesenchymal Stem CellsMesenchymal Stem Cell TransplantationRegenerative MedicineAnimalsAutoimmune DiseasesHumansimmunomodulationmesenchymal stem cellsregenerative medicinestem cell therapytissue regeneration

Identifiers

PMID40243782
PMCPMC11989115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.